Intimation of Audited Financial Results for FY 2025-26
AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amanta Healthcare reported annual revenue of Rs. 28,768 lakhs for FY 2025-26, up ~4.7% from Rs. 27,471 lakhs in the prior year. Profit after tax grew 41.6% to Rs. 1,488 lakhs from Rs. 1,050 lakhs. The company completed its IPO in September 2025, raising Rs. 12,600 lakhs, of which Rs. 7,353 lakhs has been utilized for capital expenditure on new manufacturing lines (SteriPort and SVP) at the Hariyala facility, with Rs. 5,247 lakhs still unutilized. An exceptional charge of Rs. 262.88 lakhs was recognized for IPO expenses related to listing existing shares. Operating cash flow was strong at Rs. 4,845 lakhs. Auditors Price Waterhouse Chartered Accountants LLP issued an unmodified (clean) opinion with no going concern or emphasis of matter flags.
Solid profit growth with a clean audit opinion. The large unutilized IPO proceeds and high capex spending suggest meaningful future capacity expansion. The exceptional item is non-recurring and not a concern.